Back
Corporate News
Johnson Pharmacare Ltd. to approve quarterly results at a board meeting on August 13
08-Aug-2026, 08:44
Johnson Pharmacare Ltd. will hold a board meeting on Thursday, August 13, to approve the unaudited standalone financial results for the quarter ended June 30, 2026, according to a regulatory filing with the BSE Limited. The company closed its trading window on July 1, 2026, and it will remain closed until 48 hours after the unaudited results are declared.
Johnson Pharmacare Ltd. will hold a board meeting on Thursday, August 13, to approve the unaudited standalone financial results for the quarter ended June 30, 2026, according to a regulatory filing with the BSE Limited. The company closed its trading window on July 1, 2026, and it will remain closed until 48 hours after the unaudited results are declared.